ABT-670 is a drug which acts as a potent, orally bioavailable
dopamine agonist selective for the
D4 subtype, which was developed as a possible treatment for
erectile dysfunction,[1] although its current uses are limited to scientific research.[2]
^Patel MV, Kolasa T, Mortell K, Matulenko MA, Hakeem AA, Rohde JJ, et al. (December 2006). "Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction". Journal of Medicinal Chemistry. 49 (25): 7450–65.
doi:
10.1021/jm060662k.
PMID17149874.
^Richards N, Wayman C, Allers KA (November 2009). "Electrophysiological actions of the dopamine agonist apomorphine in the paraventricular nucleus during penile erection". Neuroscience Letters. 465 (3): 242–7.
doi:
10.1016/j.neulet.2009.08.078.
PMID19733217.
S2CID27767274.